Journal article · 2020 · Open access

Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal

Mamadou Alpha Diallo, Mamadou Samb YADE, Yaye Dié Ndiaye, Ibrahima Diallo, Khadim Diongue, Saidou Abdoul Sy, Mouhamad Sy, Mame Cheikh Seck, Mouhamadou Ndiaye, Baba Dièye, Jules François Gomis, Djiby Sow and 3 more

Scientific Reports, 10(1), 8907 · Published 1 June 2020 · DOI 10.1038/s41598-020-65553-5

Open PDFView at the publisherCite this paper

In brief

“Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal” is a 2020 journal article by Mamadou Alpha Diallo and 14 co-authors, published in Scientific Reports. OpenAlex counts 70 citations as of 19 November 2026, which puts it in the top 6% of works published in 2020 by citations. It is open access under a CC BY licence: the full text is free to read at Scientific Reports.

Citations
70
Most cited in
2021 (25)
Field-weighted impact
7.50
References
48
Authors
15

Abstract

In 2006, Senegal adopted artemisinin-based combination therapy (ACT) as first-line treatment in the management of uncomplicated malaria. This study aimed to update the status of antimalarial efficacy more than ten years after their first introduction. This was a randomized, three-arm, open-label study to evaluate the efficacy and safety of artemether-lumefantrine (AL), artesunate-amodiaquine (ASAQ) and dihydroartemisinin-piperaquine (DP) in Senegal. Malaria suspected patients were screened, enrolled, treated, and followed for 28 days for AL and ASAQ arms or 42 days for DP arm. Clinical and parasitological responses were assessed following antimalarial treatment. Genotyping (msp1, msp2 and 24 SNP-based barcode) were done to differentiate recrudescence from re-infection; in case of PCR-confirmed treatment failure, Pfk13 propeller and Pfcoronin genes were sequenced. Data was entered and analyzed using the WHO Excel-based application. A total of 496 patients were enrolled. In Diourbel, PCR non-corrected/corrected adequate clinical and parasitological responses (ACPR) was 100.0% in both the AL and ASAQ arms. In Kedougou, PCR corrected ACPR values were 98.8%, 100% and 97.6% in AL, ASAQ and DP arms respectively. No Pfk13 or Pfcoronin mutations associated with artemisinin resistance were found. This study showed that AL, ASAQ and DP remain efficacious and well-tolerated in the treatment of uncomplicated P. falciparum malaria in Senegal.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Diallo, M. A., YADE, M. S., Ndiaye, Y. D., Diallo, I., Diongue, K., Sy, S. A., Sy, M., Seck, M. C., Ndiaye, M., Dièye, B., Gomis, J. F., Sow, D., Dème, A. B., Badiane, A. S., & Ndiaye, D. (2020). Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal. Scientific Reports, 10(1), 8907. https://doi.org/10.1038/s41598-020-65553-5

MLA 9

Diallo, Mamadou Alpha, et al. “Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal.” Scientific Reports, vol. 10, no. 1, 2020, p. 8907. https://doi.org/10.1038/s41598-020-65553-5.

Chicago

Diallo, Mamadou Alpha, Mamadou Samb YADE, Yaye Dié Ndiaye, Ibrahima Diallo, Khadim Diongue, Saidou Abdoul Sy, Mouhamad Sy, et al. 2020. “Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal.” Scientific Reports 10 (1): 8907. https://doi.org/10.1038/s41598-020-65553-5.

Harvard

Diallo, M. A. et al. (2020) ‘Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal’, Scientific Reports, 10(1), p. 8907. doi:10.1038/s41598-020-65553-5.

IEEE

M. A. Diallo et al., “Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal,” Scientific Reports, vol. 10, no. 1, p. 8907, 2020, doi: 10.1038/s41598-020-65553-5.

BibTeX

@article{diallo2020efficacy,
  title     = {{Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal}},
  author    = {Diallo, Mamadou Alpha and YADE, Mamadou Samb and Ndiaye, Yaye Dié and Diallo, Ibrahima and Diongue, Khadim and Sy, Saidou Abdoul and Sy, Mouhamad and Seck, Mame Cheikh and Ndiaye, Mouhamadou and Dièye, Baba and Gomis, Jules François and Sow, Djiby and Dème, Awa B. and Badiane, Aïda Sadikh and Ndiaye, Daouda},
  journal   = {Scientific Reports},
  year      = {2020},
  volume    = {10},
  number    = {1},
  pages     = {8907},
  doi       = {10.1038/s41598-020-65553-5},
  url       = {https://doi.org/10.1038/s41598-020-65553-5}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202033
20212525
202277
20231313
20241414
202566
202622

Its field-weighted citation impact is 7.50: it has been cited 7.50 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control

  • artemisinin-based combination therapy
  • uncomplicated malaria
  • Plasmodium falciparum
  • artemether-lumefantrine
  • artesunate-amodiaquine
  • dihydroartemisinin-piperaquine
  • treatment efficacy
  • treatment safety

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Diallo, M. A., YADE, M. S., Ndiaye, Y. D., Diallo, I., Diongue, K., Sy, S. A., Sy, M., Seck, M. C., Ndiaye, M., Dièye, B., Gomis, J. F., Sow, D., Dème, A. B., Badiane, A. S., & Ndiaye, D. (2020). Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal. Scientific Reports, 10(1), 8907. https://doi.org/10.1038/s41598-020-65553-5

How many times has this paper been cited?

70 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Scientific Reports: sign in and open the PDF from this page.

Who wrote this paper?

Mamadou Alpha Diallo, Mamadou Samb YADE, Yaye Dié Ndiaye, Ibrahima Diallo, Khadim Diongue, Saidou Abdoul Sy, Mouhamad Sy, Mame Cheikh Seck, Mouhamadou Ndiaye, Baba Dièye, Jules François Gomis, Djiby Sow and 3 more.

What is the DOI of this paper?

10.1038/s41598-020-65553-5, permanently at https://doi.org/10.1038/s41598-020-65553-5. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.